Endurance Wealth Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-159,703
| Closed | -$2.42M | – | 674 |
|
|
2022
Q3 | $2.42M | Sell |
159,703
-7,800
| -5% | -$118K | 0.4% | 56 |
|
|
2022
Q2 | $1.26M | Sell |
167,503
-5,000
| -3% | -$37.5K | 0.19% | 86 |
|
|
2022
Q1 | $1.57M | Buy |
172,503
+14,334
| +9% | +$130K | 0.2% | 81 |
|
|
2021
Q4 | $1.11M | Sell |
158,169
-46,901
| -23% | -$329K | 0.12% | 111 |
|
|
2021
Q3 | $2.34M | Buy |
205,070
+27,611
| +16% | +$315K | 0.26% | 83 |
|
|
2021
Q2 | $2.84M | Buy |
177,459
+49,859
| +39% | +$798K | 0.32% | 74 |
|
|
2021
Q1 | $2.28M | Buy |
127,600
+28,160
| +28% | +$503K | 0.27% | 82 |
|
|
2020
Q4 | $1.34M | Buy |
99,440
+97,090
| +4,131% | +$1.31M | 0.17% | 91 |
|
|
2020
Q3 | $28K | Sell |
2,350
-200
| -8% | -$2.38K | ﹤0.01% | 363 |
|
|
2020
Q2 | $37K | Sell |
2,550
-500
| -16% | -$7.26K | 0.01% | 340 |
|
|
2020
Q1 | $41K | Buy |
3,050
+750
| +33% | +$10.1K | 0.01% | 305 |
|
|
2019
Q4 | $55K | Sell |
2,300
-300
| -12% | -$7.17K | 0.01% | 275 |
|
|
2019
Q3 | $50K | Buy |
2,600
+1,650
| +174% | +$31.7K | 0.01% | 280 |
|
|
2019
Q2 | $28K | Buy |
950
+450
| +90% | +$13.3K | ﹤0.01% | 315 |
|
|
2019
Q1 | $24K | Hold |
500
| – | – | ﹤0.01% | 318 |
|
|
2018
Q4 | $18K | Buy |
500
+200
| +67% | +$7.2K | ﹤0.01% | 327 |
|
|
2018
Q3 | $18K | Hold |
300
| – | – | ﹤0.01% | 353 |
|
|
2018
Q2 | $20K | Hold |
300
| – | – | ﹤0.01% | 349 |
|
|
2018
Q1 | $16K | Buy |
300
+100
| +50% | +$5.33K | ﹤0.01% | 388 |
|
|
2017
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 401 |
|
|
2017
Q3 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 411 |
|